Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Operating Activities:    
Consolidated net loss $ (23,423) $ (8,140)
Adjustments to reconcile consolidated net loss to net cash provided by operating activities:    
Depreciation and amortization of intangibles 18,408 17,670
Interest expense added to term debt 0 9,451
Fair value adjustments (473) (16)
Amortization of debt discount 273 610
Inventory valuation adjustment 256 0
Amortization of deferred financing fees 189 75
Non-cash compensation 2,158 1,181
Loss (gain) on derivative instruments 352 (809)
Bad debt expense 2 286
Changes in operating assets and liabilities:    
Accounts receivable 39,835 (10,886)
Inventories (3,273) (5,108)
Prepaid expenses and other assets (4,454) 4,909
Prepaid inventory (486) (4,346)
Accounts payable and accrued expenses (14,273) (3,771)
Net cash provided by operating activities 15,091 1,106
Investing Activities:    
Additions to property and equipment (6,229) (7,485)
Proceeds from cash collateralized letters of credit 0 4,010
Net cash used in investing activities (6,229) (3,475)
Financing Activities:    
Net proceeds on Kinergy's line of credit 5,295 1,042
Net proceeds from notes 13,530 0
Principal payments on borrowings (4,500) (17,003)
Payments on capital leases (386) (2,079)
Proceeds from exercise of warrants and options 690 0
Preferred stock dividends paid (627) (630)
Net cash provided by (used in) financing activities 14,002 (18,670)
Net increase (decrease) in cash and cash equivalents 22,864 (21,039)
Cash and cash equivalents at beginning of period 68,590 52,712
Cash and cash equivalents at end of period 91,454 31,673
Supplemental Information:    
Interest paid 4,852 2,595
Income taxes received 3 4,784
Noncash financing and investing activities:    
Reclass of warrant liability to equity upon warrant exercises $ 178 $ 0